Marion Katz
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marion Katz.
In Vitro Cellular & Developmental Biology – Plant | 1990
John A. McLane; Marion Katz; Nana Abdelkader
Summary1,25-Dihydroxyvitamin D3 (1,25-(OH)2-D3) is known to decrease the proliferation and increase the differentiation of different cell types including human keratinocytes. The growth and differentiation of keratinocytes in the presence of 1,25-(OH)2-D3 using serum-free media formulations has been described previously. This investigation extends these studies to describe various culture conditions with human foreskin keratinocytes to determine the optimal antiproliferative activity of 1,25-(OH)2-D3. Keratinocytes were plated onto tissue culture dishes using one of three basic serum-free media protocols; a) with no feeder layer in keratinocyte growth medium (KGM); b) onto mitomycin C-treated 3T3 mouse embryo fibroblasts; or c) onto mitomycin C-treated dermal human fibroblasts. The last two protocols utilized Dulbeccos modified Eagles Medium (DMEM) supplemented with growth factors. Keratinocyte cell growth was greatest in the KGM medium. Although the growth of keratinocytes on either feeder layer was similar, there were differences in the ability of the cells to form envelopes in the presence of 1,25-(OH)2-D3. The addition of hydrocortisone and cholera toxin to the medium also affected the response of the keratinocytes to 1,25-(OH)2-D3. The antiproliferative effect of 1,25-(OH)2-D3 was not altered by varying the extracellular calcium levels from 0.25 to 3 mM. The antiproliferative activity of 1,25-(OH)2-D3 is attenuated in cells at low density. Our results suggest that an optimal condition to investigate the ability of 1,25-(OH)2-D3 to inhibit keratinocyte proliferation is at preconfluent cell density in the presence of KGM supplemented with 1.5 mM calcium without a feeder layer. These conditions are not appropriate for investigating the enhancement of differentiation by 1,25-(OH)2-D3, but can be used to assay other agents that modulate keratinocyte proliferation.
Mutation Research\/environmental Mutagenesis and Related Subjects | 1975
David Weinstein; Irving Mauer; Marion Katz; Sonja Kazmer
The effect of caffeine (I,3,7-trimethylxanthine), theophylline (I,3-dimethylxanthine), theobromine (3,7-dimethylxanthine), paraxanthine (I,7-dimethylxanthine) I-methylxanthine, 3-methylxanthine, and 7-methylxanthine added at the 48th h on the chromosomes of human lymphocytes in 72-h cultures has been investigated. Caffeine and the dimethylxanthines cause breakage at 750 mug/ml, with caffeine the most, and paraxanthine the least clastogenic. I-Methylxanthine and dimethylxanthines with a methyl group in the I-position are the most effective in depressing mitotic indices. No chromosome damage was exhibited by the monomethylxanthines.
Mutation Research | 1973
David Weinstein; Irving Mauer; Marion Katz; Sonja Kazmer
Abstract In an attempt to determine the mechanism of action of caffeine clastogenicity (chromosome breakage), substances directly or indirectly affecting the synthesis or integrity of DNA were added to caffeine-treated human lymphocyte cultures. At concentrations of 250–750 μg caffeine per ml, no evidence could be found which would indicate that caffeine was acting as a purine analogue, inhibitor of phosphodiesterase, stimulator of adenylosuccinate (S-AMP) lyase, labilizer of lysosomes, or as a clastogen which could be inhibited by an antimutagen.
Journal of Cellular Physiology | 1992
Hee-Jong Kim; Neamatallah Abdelkader; Marion Katz; John A. McLane
Mutation Research\/environmental Mutagenesis and Related Subjects | 1977
David Weinstein; Marion Katz; Sonja Kazmer
Environmental Mutagenesis | 1981
David Weinstein; Marion Katz; Sonja Kazmer
Mutation Research | 1973
David Weinstein; Irving Mauer; Marion Katz; Sonja Kazmer
Environmental Mutagenesis | 1983
Sonja Kazmer; Marion Katz; David Weinstein
Annals of the New York Academy of Sciences | 1988
John A. McLane; Marion Katz
Experimental and Clinical Endocrinology & Diabetes | 2009
Richard Pither; Stephen Game; Julie Davis; Marion Katz; John A. McLane